GPT and metabolic dysfunction-associated steatotic liver disease: Multiple studies reported that metformin minimizes serum AST and ALT levels, improves hepatic physiology, vital body measurements, homeostatic model assessment for insulin resistance (HOMA-IR), body mass index (BMI), hepatic steatosis index (HSI), and metabolic variable among cases NAFLD with or without distinction DM [212-215].